Sikiric, P., Seiwerth, S., Rucman, R., et al
PlexusDx's Precision Peptide Genetic Test identifies your genetic variants in GLP1R (rs6923761), GIPR, MC4R, and FTO genes, along with 49 other peptides affecting appetite, metabolism, and medication response
Drawing on patient research, UK prescribing trends and launch patterns observed in the United States, Simple Online Healthcare estimates oral GLP-1 treatments could reach 120,000-130,000 UK patients within the first three months of launch, with around 100,000 expected to be entirely new to obesity management medication
Based on this in-depth assessment, youll receive a custom treatment plan featuring compounded therapies such as Naltrexone and Sermorelin
[5] This science-based approach, combined with saffron's long history of culinary and medicinal use, positions Supresa as a unique player in the growing market for natural appetite management solutions